Immunology

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA Approval
FDA sign
FDA Approval
FDA Approves mFLUSIVA for Influenza Prevention in Adults Aged 50 Years and Older
08/07/2026
Anthony Calabro, MA
The FDA approved an mRNA-based influenza vaccine mFLUSIVA for adults aged 50 years and older, with accelerated approval applying to adults aged 65 years and older.
08/07/2026